Bioavailability of flavonoids: A review of their membrane transport and the function of bilitranslocase in animal and plant organisms

Current Drug Metabolism

Volumn 10, Issue 4, 2009, Pages 369-394

  Passamonti, Sabina ^a   Terdoslavich, Michela ^a   Franca, Raffaella ^a   Vanzo, Andreja ^b   Tramer, Federica ^a   Braidot, Enrico ^c   Petrussa, Elisa ^c   Vianello, Angelo ^c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b AGRICULTURAL INSTITUTE OF SLOVENIA   (Slovenia)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Bilitranslocase; Bioavailability; Flavonoids; Mammals; Membrane transporters; Plants

Indexed keywords

AMINO ACID TRANSPORTER; ANTHOCYANIN; APIGENIN; BILIRUBIN; BILITRANSLOCASE; BROMSULFOPHTHALEIN; CARRIER PROTEIN; CATECHIN; CERULOPLASMIN; COMPLEMENTARY DNA; DAIDZEIN; DELPHINIDIN; EPICATECHIN; EPIGALLOCATECHIN; ERIODICTYOL; FLAVONOID; GALLOCATECHIN; GENISTEIN; HESPERETIN; KAEMPFEROL; LUTEOLIN; MALVIDIN CHLORIDE; MONOCARBOXYLATE TRANSPORTER; NARINGENIN; NUCLEOSIDE TRANSPORTER; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; PELARGONIDIN; QUERCETIN; UNCLASSIFIED DRUG;

BILIRUBIN BLOOD LEVEL; BIOAVAILABILITY; BIOSYNTHESIS; CELL CYCLE; CELL MEMBRANE; FOOD INTAKE; FRUIT; GASTROINTESTINAL ABSORPTION; HUMAN; INTESTINE EPITHELIUM; KIDNEY EPITHELIUM; MEMBRANE TRANSPORT; NONHUMAN; REVIEW; STOMACH EPITHELIUM; TARGET CELL; TISSUE DISTRIBUTION; VALIDATION PROCESS; VEGETABLE;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOSYNTHETIC PATHWAYS; FLAVONOIDS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PLANTS;

EID: 68349144331     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009788498950     Document Type: Review

References (298)

1. Ververidis, F.; Trantas, E.; Douglas, C.; Vollmer, G.; Kretzschmar, G.; Panopoulos, N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol. J., 2007, 2(10), 1214-34.
2. Harborne, J. B.; Williams, C. A. Advances in flavonoid research since 1992. Phytochemistry, 2000, 55(6), 481-504.
3. Mennen, L. I.; Sapinho, D.; Ito, H.; Galan, P.; Hercberg, S.; Scalbert, A. Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake. Eur. J. Clin. Nutr., 2008, 62(4), 519-25.
4. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-47.
5. Kyle, J. A. M.; Duthie, G. G. Flavonoid in Foods. In Flavonoids. Chemistry, Biochemistry and Applications, Andersen, M. Ø.; Markham, K. R., Eds.; CRC Taylor & Francis Group: Boca Raton, 2006, pp. 219-262.
6. USDA USDA Database for the Flavonoid Content of Selected Foods. Release 2.1, 2007.
7. Mattivi, F.; Guzzon, R.; Vrhovsek, U.; Stefanini, M.; Velasco, R. Metabolite Profiling of Grape: Flavonols and Anthocyanins. J. Agric. Food Chem., 2006, 54, 7692-7702.
8. Wu, X.; Beecher, G. R.; Holden, J. M.; Haytowitz, D. B.; Gebhardt, S. E.; Prior, R. L. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem., 2006, 54(11), 4069-75.
9. Slimestad, R.; Fossen, T.; Vagen, I. M. Onions: a source of unique dietary flavonoids. J. Agric. Food Chem., 2007, 55(25), 10067-80.
10. Somerset, S. M.; Johannot, L. Dietary flavonoid sources in Australian adults. Nutr. Cancer, 2008, 60(4), 442-9.
11. Lee, K. W.; Kim, Y. J.; Lee, H. J.; Lee, C. Y. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J. Agric. Food Chem., 2003, 51(25), 7292-5.
12. Reinli, K.; Block, G. Phytoestrogen content of foods--a compendium of literature values. Nutr. Cancer, 1996, 26(2), 123-48.
13. Gil-Izquierdo, A.; Gil, M. I.; Ferreres, F.; Tomas-Barberan, F. A. In vitro availability of flavonoids and other phenolics in orange juice. J. Agric. Food Chem., 2001, 49(2), 1035-41.
14. Miean, K. H.; Mohamed, S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem., 2001, 49(6), 3106-12.
15. Yao, L. H.; Jiang, Y. M.; Shi, J.; Tomas-Barberan, F. A.; Datta, N.; Singanusong, R.; Chen, S. S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr., 2004, 59(3), 113-22.
16. Kris-Etherton, P. M.; Lefevre, M.; Beecher, G. R.; Gross, M. D.; Keen, C. L.; Etherton, T. D. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu. Rev. Nutr., 2004, 24, 511-38.
17. WHO The top ten causes of death; Fact sheet 310; WHO Media centre: 2008.
18. Geleijnse, J. M.; Hollman, P. Flavonoids and cardiovascular health: which compounds, what mechanisms? Am. J. Clin. Nutr., 2008, 88(1), 12-3.
19. Hooper, L.; Kroon, P. A.; Rimm, E. B.; Cohn, J. S.; Harvey, I.; Le Cornu, K. A.; Ryder, J. J.; Hall, W. L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2008, 88(1), 38-50.
20. Mursu, J.; Nurmi, T.; Tuomainen, T. P.; Salonen, J. T.; Pukkala, E.; Voutilainen, S. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int. J. Cancer, 2008, 123(3), 660-3.
21. WHO Neurological Disorders: Public Health Challenges; 978 92 4 156336 9; WHO Press: Geneva, 2007, p. 218.
22. Letenneur, L.; Proust-Lima, C.; Le Gouge, A.; Dartigues, J. F.; Barberger-Gateau, P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol., 2007, 165(12), 1364-71.
23. WHO Diabetes; Fact sheet 312; WHO Media Center, 2006.
24. WHO Obesity and Overweight; Fact Sheet 311; WHO Media centre, 2006.
25. Pinent, M.; Blade, C.; Salvado, M. J.; Blay, M.; Pujadas, G.; Fernandez-Larrea, J.; Arola, L.; Ardevol, A. Procyanidin effects on adipocyte-related pathologies. Crit. Rev. Food Sci. Nutr., 2006, 46(7), 543-50.
26. Jung, M.; Park, M.; Lee, H. C.; Kang, Y. H.; Kang, E. S.; Kim, S. K. Antidiabetic agents from medicinal plants. Curr. Med. Chem., 2006, 13(10), 1203-18.
27. WHO Global Strategy on Diet, Physical Activity and Health, 2004.
28. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 1996, 20(7), 933-56.
29. Finkel, T.; Holbrook, N. J. Oxidants, oxidative stress and the biology of ageing. Nature, 2000, 408(6809), 239-47.
30. Pieczenik, S. R.; Neustadt, J. Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol., 2007, 83(1), 84-92.
31. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230S-42S.
32. Lotito, S. B.; Frei, B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 2006, 41(12), 1727-46.
33. Dangles, O.; Dufour, C. Flavonoid-Protein Interactions. In Flavonoid in Foods in Flavonoids. Chemistry, Biochemistry and Applications, Andersen, M. Ø.; Markham, K. R., Eds.; CRC Taylor & Francis Group: Boca Raton, 2006, pp. 443-469.
34. Williams, R. J.; Spencer, J. P.; Rice-Evans, C. Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36(7), 838-49.
35. Teillet, F.; Boumendjel, A.; Boutonnat, J.; Ronot, X. Flavonoids as RTK inhibitors and potential anticancer agents. Med. Res. Rev., 2008, 28(5), 715-45.
36. Shukitt-Hale, B.; Lau, F. C.; Joseph, J. A. Berry fruit supplementation and the aging brain. J. Agric. Food Chem., 2008, 56(3), 636-41.
37. Vauzour, D.; Vafeiadou, K.; Rodriguez-Mateos, A.; Rendeiro, C.; Spencer, J. P. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr., 2008, 3(3-4), 115-26.
38. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res., 2008, 52(5), 507-26.
39. Singh, R. P.; Agarwal, R. Natural flavonoids targeting deregulated cell cycle progression in cancer cells. Curr. Drug Targets, 2006, 7(3), 345-54.
40. Biesalski, H. K. Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care, 2007, 10(6), 724-8.
41. Rahman, I.; Biswas, S. K.; Kirkham, P. A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72(11), 1439-52.
42. Moutsatsou, P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens), 2007, 6(3), 173-93.
43. Cermak, R. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin. Drug Metab. Toxicol., 2008, 4(1), 17-35.
44. Lambert, J. D.; Sang, S.; Lu, A. Y.; Yang, C. S. Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab., 2007, 8(5), 499-507.
45. Moon, Y. J.; Wang, X.; Morris, M. E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. in Vitro, 2006, 20(2), 187-210.
46. Turner, J. R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am. J. Pathol., 2006, 169(6), 1901-9.
47. Kim, H. R.; Park, S. W.; Cho, H. J.; Chae, K. A.; Sung, J. M.; Kim, J. S.; Landowski, C. P.; Sun, D.; Abd El-Aty, A. M.; Amidon, G. L.; Shin, H. C. Comparative gene expression profiles of intestinal transporters in mice, rats and humans. Pharmacol. Res., 2007, 56(3), 224-36.
48. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46(1-3), 3-26.
49. Cooper, G. J.; Zhou, Y.; Bouyer, P.; Grichtchenko, II; Boron, W. F. Transport of volatile solutes through AQP1. J. Physiol., 2002, 542(Pt 1), 17-29.
50. Ludewig, U. Ion transport versus gas conduction: function of AMT/Rh-type proteins. Transfus. Clin. Biol., 2006, 13(1-2), 111-6.
51. Lodish, H.; Berk, A.; Zipursky, S. L.; Matsudaira, P.; Baltimore, D.; Darnell, J. E. Molecular Cell Biology, W. H. Freeman & Co.: New York, 1999.
52. Dean, M.; Allikmets, R. Complete characterization of the human ABC gene family. J. Bioenerg. Biomembr., 2001, 33(6), 475-9.
53. Uldry, M.; Thorens, B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch., 2004, 447(5), 480-9.
54. Wright, E. M.; Hirayama, B. A.; Loo, D. F. Active sugar transport in health and disease. J. Intern. Med., 2007, 261(1), 32-43.
55. +-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp. Physiol., 2007, 92(4), 603-19.
56. Di Pietro, A.; Conseil, G.; Perez-Victoria, J. M.; Dayan, G.; Baubichon-Cortay, H.; Trompier, D.; Steinfels, E.; Jault, J. M.; de Wet, H.; Maitrejean, M.; Comte, G.; Boumendjel, A.; Mariotte, A. M.; Dumontet, C.; McIntosh, D. B.; Goffeau, A.; Castanys, S.; Gamarro, F.; Barron, D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci., 2002, 59(2), 307-22.
57. Morris, M. E.; Zhang, S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci., 2006, 78(18), 2116-30.
58. Brand, W.; Schutte, M. E.; Williamson, G.; van Zanden, J. J.; Cnubben, N. H.; Groten, J. P.; van Bladeren, P. J.; Rietjens, I. M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed. Pharmacother., 2006, 60(9), 508-19.
59. Ahmed-Belkacem, A.; Pozza, A.; Macalou, S.; Perez-Victoria, J. M.; Boumendjel, A.; Di Pietro, A. Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2). Anticancer. Drugs, 2006, 17(3), 239-43.
60. Boumendjel, A.; Baubichon-Cortay, H.; Trompier, D.; Perrotton, T.; Di Pietro, A. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents. Med. Res. Rev., 2005, 25(4), 453-72.
61. Sai, Y.; Tsuji, A. Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov. Today, 2004, 9(16), 712-20.
62. Kim, R. B. Transporters and drug discovery: why, when, and how. Mol. Pharm., 2006, 3(1), 26-32.
63. Kirby, B. J.; Unadkat, J. D. Grapefruit juice, a glass full of drug interactions? Clin. Pharmacol. Ther., 2007, 81(5), 631-3.
64. Manach, C.; Donovan, J. L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic. Res., 2004, 38(8), 771-85.
65. Hollman, P. C.; de Vries, J. H.; van Leeuwen, S. D.; Mengelers, M. J.; Katan, M. B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., 1995, 62(6), 1276-82.
66. Walgren, R. A.; Lin, J. T.; Kinne, R. K.; Walle, T. Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1. J. Pharmacol. Exp. Ther., 2000, 294(3), 837-43.
67. Drozdowski, L. A.; Thomson, A. B. Intestinal sugar transport. World J. Gastroenterol., 2006, 12(11), 1657-70.
68. Day, A. J.; Gee, J. M.; DuPont, M. S.; Johnson, I. T.; Williamson, G. Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem. Pharmacol., 2003, 65(7), 1199-206.
69. Gee, J. M.; DuPont, M. S.; Day, A. J.; Plumb, G. W.; Williamson, G.; Johnson, I. T. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J. Nutr., 2000, 130(11), 2765-71.
70. Wolffram, S.; Block, M.; Ader, P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J. Nutr., 2002, 132(4), 630-5.
71. Arts, I. C.; Sesink, A. L.; Hollman, P. C. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J. Nutr., 2002, 132(9), 2823; author reply 2824.
72. Walle, T.; Walle, U. K. The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. Drug Metab. Dispos., 2003, 31(11), 1288-91.
73. Chen, C. H.; Hsu, H. J.; Huang, Y. J.; Lin, C. J. Interaction of flavonoids and intestinal facilitated glucose transporters. Planta Med., 2007, 73(4), 348-54.
74. Kwon, O.; Eck, P.; Chen, S.; Corpe, C. P.; Lee, J. H.; Kruhlak, M.; Levine, M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J., 2007, 21(2), 366-77.
75. Song, J.; Kwon, O.; Chen, S.; Daruwala, R.; Eck, P.; Park, J. B.; Levine, M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J. Biol. Chem., 2002, 277(18), 15252-60.
76. Kottra, G.; Daniel, H. Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J. Pharmacol. Exp. Ther., 2007, 322(2), 829-35.
77. Bazuine, M.; van den Broek, P. J.; Maassen, J. A. Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2005, 326(2), 511-4.
78. Strobel, P.; Allard, C.; Perez-Acle, T.; Calderon, R.; Aldunate, R.; Leighton, F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J., 2005, 386(Pt 3), 471-8.
79. Cunningham, P.; Afzal-Ahmed, I.; Naftalin, R. J. Docking studies show that D-glucose and quercetin slide through the transporter GLUT1. J. Biol. Chem., 2006, 281(9), 5797-803.
80. Vera, J. C.; Reyes, A. M.; Velasquez, F. V.; Rivas, C. I.; Zhang, R. H.; Strobel, P.; Slebe, J. C.; Nunez-Alarcon, J.; Golde, D. W. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry, 2001, 40(3), 777-90.
81. Ader, P.; Block, M.; Pietzsch, S.; Wolffram, S. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett., 2001, 162(2), 175-80.
82. Cermak, R.; Landgraf, S.; Wolffram, S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr., 2004, 91(6), 849-55.
83. Johnston, K.; Sharp, P.; Clifford, M.; Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett., 2005, 579(7), 1653-7.
84. Kobayashi, Y.; Suzuki, M.; Satsu, H.; Arai, S.; Hara, Y.; Suzuki, K.; Miyamoto, Y.; Shimizu, M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J. Agric. Food Chem., 2000, 48(11), 5618-23.
85. Li, J. M.; Che, C. T.; Lau, C. B.; Leung, P. S.; Cheng, C. H. Inhibition of intestinal and renal Na+-glucose cotransporter by naringenin. Int. J. Biochem. Cell Biol., 2006, 38(5-6), 985-95.
86. Ehrenkranz, J. R.; Lewis, N. G.; Kahn, C. R.; Roth, J. Phlorizin: a review. Diabetes. Metab. Res. Rev., 2005, 21(1), 31-8.
87. Riccardi, G.; Rivellese, A. A.; Giacco, R. Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am. J. Clin. Nutr., 2008, 87(1), 269S-274S.
88. Broer, S.; Broer, A.; Schneider, H. P.; Stegen, C.; Halestrap, A. P.; Deitmer, J. W. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J., 1999, 341 (Pt 3), 529-35.
89. Meredith, D.; Christian, H. C. The SLC16 monocarboxylate transporter family. Xenobiotica, 2008, 38(7-8), 1072-106.
90. Bonen, A.; Heynen, M.; Hatta, H. Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl. Physiol. Nutr. Metab., 2006, 31(1), 31-9.
91. Wang, Q.; Morris, M. E. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab. Dispos., 2007, 35(2), 201-8.
92. Wang, X.; Wang, Q.; Morris, M. E. Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters. AAPS J., 2008, 10(1), 47-55.
93. Shim, C. K.; Cheon, E. P.; Kang, K. W.; Seo, K. S.; Han, H. K. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J. Pharm. Pharmacol., 2007, 59(11), 1515-9.
94. Anzai, N.; Kanai, Y.; Endou, H. Organic anion transporter family: current knowledge. J. Pharmacol. Sci., 2006, 100(5), 411-26.
95. Sekine, T.; Miyazaki, H.; Endou, H. Molecular physiology of renal organic anion transporters. Am. J. Physiol. Renal Physiol., 2006, 290(2), F251-61.
96. Hong, S. S.; Seo, K.; Lim, S. C.; Han, H. K. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol. Res., 2007, 56(6), 468-73.
97. Hagenbuch, B.; Gui, C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica, 2008, 38(7-8), 778-801.
98. Dresser, G. K.; Bailey, D. G.; Leake, B. F.; Schwarz, U. I.; Dawson, P. A.; Freeman, D. J.; Kim, R. B. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther., 2002, 71(1), 11-20.
99. Fuchikami, H.; Satoh, H.; Tsujimoto, M.; Ohdo, S.; Ohtani, H.; Sawada, Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos., 2006, 34(4), 577-82.
100. Satoh, H.; Yamashita, F.; Tsujimoto, M.; Murakami, H.; Koyabu, N.; Ohtani, H.; Sawada, Y. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos., 2005, 33(4), 518-23.
101. Wang, X.; Wolkoff, A. W.; Morris, M. E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab. Dispos., 2005, 33(11), 1666-72.
102. Broer, S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol. Rev., 2008, 88(1), 249-86.
103. Kong, W.; Engel, K.; Wang, J. Mammalian nucleoside transporters. Curr. Drug Metab., 2004, 5(1), 63-84.
104. Rubio-Aliaga, I.; Daniel, H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica, 2008, 38(7-8), 1022-42.
105. Choi, M. K.; Song, I. S. Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug. Metab. Pharmacokinet., 2008, 23(4), 243-53.
106. Sottocasa, G. L.; Lunazzi, G. C.; Tiribelli, C. Isolation of bilitranslocase, the anion transporter from liver plasma membrane for bilirubin and other organic anions. Methods Enzymol., 1989, 174, 50-7.
107. Tiribelli, C.; Lunazzi, G.; Luciani, M.; Panfili, E.; Gazzin, B.; Liut, G.; Sandri, G.; Sottocasa, G. L. Isolation of a sulfobromophthaleinbinding protein from hepatocyte plasma membrane. Biochim. Biophys. Acta, 1978, 532(1), 105-12.
108. Sottocasa, G. L.; Baldini, G.; Sandri, G.; Lunazzi, G.; Tiribelli, C. Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase. Biochim. Biophys. Acta, 1982, 685(2), 123-8.
109. Miccio, M.; Lunazzi, G. C.; Gazzin, B.; Sottocasa, G. L. Reconstitution of sulfobromophthalein transport in erythrocyte membranes induced by bilitranslocase. Biochim. Biophys. Acta, 1990, 1023(1), 140-2.
110. Baldini, G.; Passamonti, S.; Lunazzi, G. C.; Tiribelli, C.; Sottocasa, G. L. Cellular localization of sulfobromophthalein transport activity in rat liver. Biochim. Biophys. Acta, 1986, 856(1), 1-10.
111. Miccio, M.; Baldini, G.; Basso, V.; Gazzin, B.; Lunazzi, G. C.; Tiribelli, C.; Sottocasa, G. L. Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromophthalein in plasma membrane vesicles from rat liver: immunochemical evidence using mono- and poly-clonal antibodies. Biochim. Biophys. Acta, 1989, 981(1), 115-20.
112. Passamonti, S.; Sottocasa, G. L. The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. Biochim. Biophys. Acta, 1988, 943(2), 119-25.
113. Passamonti, S.; Battiston, L.; Sottocasa, G. L. Bilitranslocase can exist in two metastable forms with different affinities for the substrates - evidence from cysteine and arginine modification. Eur. J. Biochem., 1998, 253(1), 84-90.
114. Passamonti, S.; Vrhovsek, U.; Mattivi, F. The interaction of anthocyanins with bilitranslocase. Biochem. Biophys. Res. Commun., 2002, 296(3), 631-6.
115. Karawajczyk, A.; Drgan, V.; Medic, N.; Oboh, G.; Passamonti, S.; Novic, M. Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling. Biochem. Pharmacol., 2007, 73(2), 308-20.
116. Passamonti, S.; Cocolo, A.; Braidot, E.; Petrussa, E.; Peresson, C.; Medic, N.; Macri, F.; Vianello, A. Characterization of electrogenic bromosulfophthalein transport in carnation petal microsomes and its inhibition by antibodies against bilitranslocase. FEBS J., 2005, 272(13), 3282-96.
117. Passamonti, S.; Terdoslavich, M.; Margon, A.; Cocolo, A.; Medic, N.; Micali, F.; Decorti, G.; Franko, M. Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. FEBS J., 2005, 272(21), 5522-35.
118. Maines, M. D. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda), 2005, 20, 382-9.
119. Ryter, S. W.; Alam, J.; Choi, A. M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev., 2006, 86(2), 583-650.
120. Chandra, P.; Brouwer, K. L. The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res., 2004, 21(5), 719-35.
121. Brouillard, R. Chemical structure of anthocyanins. In Anthocyanins as Food Colors; Markakis, P., Ed.; Academic Press: New York, 1982, pp. 1-40.
122. Mazza, G., Miniati, E. Anthocyanins in fruits, vegetables and grains. CRC Press: Boca Raton, Florida, 1993; p 379.
123. Zupan, J.; Novic, M.; Ruisanchez, I. Kohonen and counterpropagation artificial neural networks in analytical chemistry. Chemometrics Intell. Lab. Syst., 1997, 38(1), 1-23.
124. Battiston, L.; Passamonti, S.; Macagno, A.; Sottocasa, G. L. The bilirubin-binding motif of bilitranslocase and its relation to conserved motifs in ancient biliproteins. Biochem. Biophys. Res. Commun., 1998, 247(3), 687-92.
125. Schirmer, T.; Bode, W.; Huber, R. Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J. Mol. Biol., 1987, 196(3), 677-95.
126. Saier, M. H., Jr. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev., 2000, 64(2), 354-411.
127. Harris, E. D. Copper transport: an overview. Proc. Soc. Exp. Biol. Med., 1991, 196(2), 130-40.
128. Healy, J.; Tipton, K. Ceruloplasmin and what it might do. J. Neural Transm., 2007, 114(6), 777-81.
129. Calabrese, L.; Carbonaro, M.; Musci, G. Presence of coupled trinuclear copper cluster in mammalian ceruloplasmin is essential for efficient electron transfer to oxygen. J. Biol. Chem., 1989, 264(11), 6183-7.
130. Gitlin, J. D. Aceruloplasminemia. Pediatr. Res., 1998, 44(3), 271-6.
131. Osaki, S.; Johnson, D. A.; Frieden, E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem., 1966, 241(12), 2746-51.
132. Ohkawa, J.; Okada, N.; Shinmyo, A.; Takano, M. Primary structure of cucumber (Cucumis sativus) ascorbate oxidase deduced from cDNA sequence: homology with blue copper proteins and tissue-specific expression. Proc. Natl. Acad. Sci. USA, 1989, 86(4), 1239-43.
133. Takahashi, N.; Bauman, R. A.; Ortel, T. L.; Dwulet, F. E.; Wang, C. C.; Putnam, F. W. Internal triplication in the structure of human ceruloplasmin. Proc. Natl. Acad. Sci. USA, 1983, 80(1), 115-9.
134. Koschinsky, M. L.; Chow, B. K.; Schwartz, J.; Hamerton, J. L.; MacGillivray, R. T. Isolation and characterization of a processed gene for human ceruloplasmin. Biochemistry, 1987, 26(24), 7760-7.
135. Royle, N. J.; Irwin, D. M.; Koschinsky, M. L.; MacGillivray, R. T.; Hamerton, J. L. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat. Cell Mol. Genet., 1987, 13(3), 285-92.
136. Wang, H.; Koschinsky, M.; Hamerton, J. L. Localization of the processed gene for human ceruloplasmin to chromosome region 8q21.13 - q23.1 by in situ hybridization. Cytogenet. Cell Genet., 1988, 47(4), 230-1.
137. Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M. C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; Kodzius, R.; Shimokawa, K.; Bajic, V. B.; Brenner, S. E.; Batalov, S.; Forrest, A. R.; Zavolan, M.; Davis, M. J.; Wilming, L. G.; Aidinis, V.; Allen, J. E.; Ambesi-Impiombato, A.; Apweiler, R.; Aturaliya, R. N.; Bailey, T. L.; Bansal, M.; Baxter, L.; Beisel, K. W.; Bersano, T.; Bono, H.; Chalk, A. M.; Chiu, K. P.; Choudhary, V.; Christoffels, A.; Clutterbuck, D. R.; Crowe, M. L.; Dalla, E.; Dalrymple, B. P.; de Bono, B.; Della Gatta, G.; di Bernardo, D.; Down, T.; Engstrom, P.; Fagiolini, M.; Faulkner, G.; Fletcher, C. F.; Fukushima, T.; Furuno, M.; Futaki, S.; Gariboldi, M.; Georgii-Hemming, P.; Gingeras, T. R.; Gojobori, T.; Green, R. E.; Gustincich, S.; Harbers, M.; Hayashi, Y.; Hensch, T. K.; Hirokawa, N.; Hill, D.; Huminiecki, L.; Iacono, M.; Ikeo, K.; Iwama, A.; Ishikawa, T.; Jakt, M.; Kanapin, A.; Katoh, M.; Kawasawa, Y.; Kelso, J.; Kitamura, H.; Kitano, H.; Kollias, G.; Krishnan, S. P.; Kruger, A.; Kummerfeld, S. K.; Kurochkin, I. V.; Lareau, L. F.; Lazarevic, D.; Lipovich, L.; Liu, J.; Liuni, S.; McWilliam, S.; Madan Babu, M.; Madera, M.; Marchionni, L.; Matsuda, H.; Matsuzawa, S.; Miki, H.; Mignone, F.; Miyake, S.; Morris, K.; Mottagui-Tabar, S.; Mulder, N.; Nakano, N.; Nakauchi, H.; Ng, P.; Nilsson, R.; Nishiguchi, S.; et al. The transcriptional landscape of the mammalian genome. Science, 2005, 309(5740), 1559-63.
138. Katayama, S.; Tomaru, Y.; Kasukawa, T.; Waki, K.; Nakanishi, M.; Nakamura, M.; Nishida, H.; Yap, C. C.; Suzuki, M.; Kawai, J.; Suzuki, H.; Carninci, P.; Hayashizaki, Y.; Wells, C.; Frith, M.; Ravasi, T.; Pang, K. C.; Hallinan, J.; Mattick, J.; Hume, D. A.; Lipovich, L.; Batalov, S.; Engstrom, P. G.; Mizuno, Y.; Faghihi, M. A.; Sandelin, A.; Chalk, A. M.; Mottagui-Tabar, S.; Liang, Z.; Lenhard, B.; Wahlestedt, C. Antisense transcription in the mammalian transcriptome. Science, 2005, 309(5740), 1564-6.
139. Claverie, J. M. Fewer genes, more noncoding RNA. Science, 2005, 309(5740), 1529-30.
140. Yazgan, O.; Krebs, J. E. Noncoding but nonexpendable: transcriptional regulation by large noncoding RNA in eukaryotes. Biochem. Cell Biol., 2007, 85(4), 484-96.
141. Okada, Y.; Tashiro, C.; Numata, K.; Watanabe, K.; Nakaoka, H.; Yamamoto, N.; Okubo, K.; Ikeda, R.; Saito, R.; Kanai, A.; Abe, K.; Tomita, M.; Kiyosawa, H. Comparative expression analysis uncovers novel features of endogenous antisense transcription. Hum. Mol. Genet., 2008, 17(11), 1631-40.
142. Royo, H.; Cavaille, J. Non-coding RNAs in imprinted gene clusters. Biol. Cell., 2008, 100(3), 149-66.
143. Werner, A. Natural antisense transcripts. RNA Biol., 2005, 2(2), 53-62.
144. Yasuda, J.; Hayashizaki, Y. The RNA continent. Adv. Cancer Res., 2008, 99, 77-112.
145. Wahlestedt, C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov. Today, 2006, 11(11-12), 503-8.
146. Yin, Y.; Zhao, Y.; Wang, J.; Liu, C.; Chen, S.; Chen, R.; Zhao, H. antiCODE: a natural sense-antisense transcripts database. BMC Bioinformat., 2007, 8, 319.
147. Zhang, Y.; Li, J.; Kong, L.; Gao, G.; Liu, Q. R.; Wei, L. NATsDB: Natural Antisense Transcripts DataBase. Nucleic Acids Res., 2007, 35(Database issue), D156-61.
148. Passamonti, S.; Vanzo, A.; Vrhovsek, U.; Terdoslavich, M.; Cocolo, A.; Decorti, G.; Mattivi, F. Hepatic uptake of grape anthocyanins and the role of bilitranslocase. Food Res. Int., 2005, 38, 953-960.
149. Brodersen, R. Binding of bilirubin to albumin. CRC Crit. Rev. Clin. Lab. Sci., 1980, 11(4), 305-99.
150. Ahlfors, C. E. Bilirubin-albumin binding and free bilirubin. J. Perinatol., 2001, 21 Suppl 1, S40-2; discussion S59-62.
151. Franko; M. Recent applications of thermal lens spectrometry in food analysis and environmental research. Talanta, 2001, 54, 1-13.
152. Fawcett, D. W. The esophagus and stomach. In Bloom and Fawcett, a Textbook of Histology; 12th ed.; Fawcett, D. W., Ed.; Chapman & Hall: New York, 1994; pp. 593-616.
153. Battiston, L.; Macagno, A.; Passamonti, S.; Micali, F.; Sottocasa, G. L. Specific sequence-directed anti-bilitranslocase antibodies as a tool to detect potentially bilirubin-binding proteins in different tissues of the rat. FEBS Lett., 1999, 453(3), 351-5.
154. Nicolin, V.; Grill, V.; Micali, F.; Narducci, P.; Passamonti, S. Immunolocalisation of bilitranslocase in mucosecretory and parietal cells of the rat gastric mucosa. J. Mol. Histol., 2005, 36(1), 45-50.
155. van den Berg, H. Bioavailability of niacin. Eur. J. Clin. Nutr., 1997, 51(Suppl 1), S64-5.
156. Guilarte, T. R.; Pravlik, K. Radiometric-microbiologic assay of niacin using Kloeckera brevis: analysis of human blood and food. J. Nutr., 1983, 113(12), 2587-94.
157. Passamonti, S.; Battiston, L.; Sottocasa, G. L. Gastric uptake of nicotinic acid by bilitranslocase. FEBS Lett., 2000, 482(1-2), 167-8.
158. Gopal, E.; Miyauchi, S.; Martin, P. M.; Ananth, S.; Roon, P.; Smith, S. B.; Ganapathy, V. Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res., 2007, 24(3), 575-84.
159. Iwanaga, T.; Takebe, K.; Kato, I.; Karaki, S.; Kuwahara, A. Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomed. Res., 2006, 27(5), 243-54.
160. Passamonti, S.; Vrhovsek, U.; Vanzo, A.; Mattivi, F. The stomach as a site for anthocyanins absorption from food. FEBS Lett., 2003, 544(1-3), 210-213.
161. Passamonti, S.; Vrhovsek, U.; Vanzo, A.; Mattivi, F. Fast Access of Some Grape Pigments to the Brain. J. Agric. Food Chem., 2005, 53(18), 7029-7034.
162. Vanzo, A.; Terdoslavich, M.; Brandoni, A.; Torres, A. M.; Vrhovsek, U.; Passamonti, S. Uptake of grape anthocyanins into the rat kidney and the involvement of bilitranslocase. Mol. Nutr. Food Res., 2008, 52(10), 1106-1116.
163. Umehara, K. I.; Seya, K.; Sonoda, T.; Nakamura, E.; Noguchi, K.; Usui, T.; Kamimura, H. Comparative evaluation of absorption, distribution, and excretion of YM758, a novel If channel inhibitor, between albino and non-albino rats. Xenobiotica, 2008, 38(5), 527-39.
164. Glaeser, H.; Bailey, D. G.; Dresser, G. K.; Gregor, J. C.; Schwarz, U. I.; McGrath, J. S.; Jolicoeur, E.; Lee, W.; Leake, B. F.; Tirona, R. G.; Kim, R. B. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther., 2007, 81(3), 362-70.
165. Sai, Y.; Kaneko, Y.; Ito, S.; Mitsuoka, K.; Kato, Y.; Tamai, I.; Artursson, P.; Tsuji, A. Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab. Dispos., 2006, 34(8), 1423-31.
166. Umehara, K.; Iwai, M.; Adachi, Y.; Iwatsubo, T.; Usui, T.; Kamimura, H. Hepatic uptake and excretion of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3, 4-tetrahydroisoquinoline-2-carbonyl)piperidino] ethyl}-4-fluorobenzamide (YM758), a novel if channel inhibitor, in rats and humans. Drug Metab. Dispos., 2008, 36(6), 1030-8.
167. Waisbren, S. J.; Geibel, J. P.; Modlin, I. M.; Boron, W. F. Unusual permeability properties of gastric gland cells. Nature, 1994, 368(6469), 332-5.
168. Felgines, C.; Talavera, S.; Texier, O.; Besson, C.; Fogliano, V.; Lamaison, J. L.; la Fauci, L.; Galvano, G.; Remesy, C.; Galvano, F. Absorption and metabolism of red orange juice anthocyanins in rats. Br. J. Nutr., 2006, 95(5), 898-904.
169. El Mohsen, M. A.; Marks, J.; Kuhnle, G.; Moore, K.; Debnam, E.; Kaila Srai, S.; Rice-Evans, C.; Spencer, J. P. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br. J. Nutr., 2006, 95(1), 51-8.
170. Felgines, C.; Texier, O.; Besson, C.; Lyan, B.; Lamaison, J. L.; Scalbert, A. Strawberry pelargonidin glycosides are excreted in urine as intact glycosides and glucuronidated pelargonidin derivatives in rats. Br. J. Nutr., 2007, 1-6.
171. Talavera, S.; Felgines, C.; Texier, O.; Besson, C.; Gil-Izquierdo, A.; Lamaison, J. L.; Remesy, C. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J. Agric. Food Chem., 2005, 53(10), 3902-8.
172. Talavera, S.; Felgines, C.; Texier, O.; Besson, C.; Lamaison, J. L.; Remesy, C. Anthocyanins Are Efficiently Absorbed from the Stomach in Anesthetized Rats. J. Nutr., 2003, 133(12), 4178-4182.
173. Matsumoto, H.; Ito, K.; Yonekura, K.; Tsuda, T.; Ichiyanagi, T.; Hirayama, M.; Konishi, T. Enhanced absorption of anthocyanins after oral administration of phytic acid in rats and humans. J. Agric. Food Chem., 2007, 55(6), 2489-96.
174. Mullen, W.; Edwards, C. A.; Serafini, M.; Crozier, A. Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J. Agric. Food Chem., 2008, 56(3), 713-9.
175. McGhie, T. K.; Walton, M. C. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol. Nutr. Food Res., 2007, 51(6), 702-13.
176. Prior, R. L.; Wu, X. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic. Res., 2006, 40(10), 1014-28.
177. Kong, F.; Singh, R. P. Disintegration of solid foods in human stomach. J. Food Sci., 2008, 73(5), R67-80.
178. Ichiyanagi, T.; Rahman, M. M.; Kashiwada, Y.; Ikeshiro, Y.; Shida, Y.; Hatano, Y.; Matsumoto, H.; Hirayama, M.; Tsuda, T.; Konishi, T. Absorption and metabolism of delphinidin 3-O-beta-D-glucopyranoside in rats. Free Radic. Biol. Med., 2004, 36(7), 930-7.
179. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; Remesy, C. Quercetin, but not its glycosides, is absorbed from the rat stomach. J. Agric. Food Chem., 2002, 50(3), 618-21.
180. Piskula, M. K.; Yamakoshi, J.; Iwai, Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett., 1999, 447(2-3), 287-91.
181. Chen, J.; Lin, H.; Hu, M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother. Pharmacol., 2005, 55(2), 159-69.
182. Eraly, S. A.; Bush, K. T.; Sampogna, R. V.; Bhatnagar, V.; Nigam, S. K. The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol. Pharmacol., 2004, 65(3), 479-87.
183. Garcia, C. K.; Brown, M. S.; Pathak, R. K.; Goldstein, J. L. cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J. Biol. Chem., 1995, 270(4), 1843-9.
184. Taiming, L.; Xuehua, J. Investigation of the absorption mechanisms of baicalin and baicalein in rats. J. Pharm. Sci., 2006, 95(6), 1326-33.
185. Konishi, Y.; Zhao, Z.; Shimizu, M. Phenolic acids are absorbed from the rat stomach with different absorption rates. J. Agric. Food Chem., 2006, 54(20), 7539-43.
186. Lafay, S.; Gil-Izquierdo, A.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A. Chlorogenic acid is absorbed in its intact form in the stomach of rats. J. Nutr., 2006, 136(5), 1192-7.
187. Vanzo, A.; Cecotti, R.; Vrhovsek, U.; Torres, A. M.; Mattivi, F.; Passamonti, S. The fate of trans-caftaric acid administered into the rat stomach. J. Agric. Food Chem., 2007, 55(4), 1604-11.
188. Zhao, Z.; Egashira, Y.; Sanada, H. Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J. Nutr., 2004, 134(11), 3083-8.
189. Yen, T. H.; Wright, N. A. The gastrointestinal tract stem cell niche. Stem Cell Rev., 2006, 2(3), 203-12.
190. Felgines, C.; Texier, O.; Besson, C.; Vitaglione, P.; Lamaison, J. L.; Fogliano, V.; Scalbert, A.; Vanella, L.; Galvano, F. Influence of glucose on cyanidin 3-glucoside absorption in rats. Mol. Nutr. Food Res., 2008, 52(8), 959-64.
191. Walton, M. C.; McGhie, T. K.; Reynolds, G. W.; Hendriks, W. H. The flavonol quercetin-3-glucoside inhibits cyanidin-3-glucoside absorption in vitro. J. Agric. Food Chem., 2006, 54(13), 4913-20.
192. Yi, W.; Akoh, C. C.; Fischer, J.; Krewer, G. Absorption of anthocyanins from blueberry extracts by caco-2 human intestinal cell monolayers. J. Agric. Food Chem., 2006, 54(15), 5651-8.
193. Steinert, R. E.; Ditscheid, B.; Netzel, M.; Jahreis, G. Absorption of black currant anthocyanins by monolayers of human intestinal epithelial Caco-2 cells mounted in ussing type chambers. J. Agric. Food Chem., 2008, 56(13), 4995-5001.
194. Yi, W.; Fischer, J.; Krewer, G.; Akoh, C. C. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J. Agric. Food Chem., 2005, 53(18), 7320-9.
195. Murota, K.; Terao, J. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett., 2005, 579(24), 5343-6.
196. Lesser, S.; Cermak, R.; Wolffram, S. Bioavailability of quercetin in pigs is influenced by the dietary fat content. J. Nutr., 2004, 134(6), 1508-11.
197. Guo, Q.; Avramoglu, R. K.; Adeli, K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism, 2005, 54(5), 689-97.
198. Shiau, Y. F.; Popper, D. A.; Reed, M.; Umstetter, C.; Capuzzi, D.; Levine, G. M. Intestinal triglycerides are derived from both endogenous and exogenous sources. Am. J. Physiol., 1985, 248(2 Pt 1), G164-9.
199. Fanous, M. Y.; Phillips, A. J.; Windsor, J. A. Mesenteric lymph: the bridge to future management of critical illness. JOP, 2007, 8(4), 374-99.
200. Elias, M. M.; Lunazzi, G. C.; Passamonti, S.; Gazzin, B.; Miccio, M.; Stanta, G.; Sottocasa, G. L.; Tiribelli, C. Bilitranslocase localization and function in basolateral plasma membrane of renal proximal tubule in rat. Am. J. Physiol., 1990, 259(4 Pt 2), F559-64.
201. Bub, A.; Watzl, B.; Heeb, D.; Rechkemmer, G.; Briviba, K. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur. J. Nutr., 2001, 40(3), 113-20.
202. Cao, G.; Muccitelli, H. U.; Sanchez-Moreno, C.; Prior, R. L. Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am. J. Clin. Nutr., 2001, 73(5), 920-6.
203. Carkeet, C.; Clevidence, B. A.; Novotny, J. A. Anthocyanin excretion by humans increases linearly with increasing strawberry dose. J. Nutr., 2008, 138(5), 897-902.
204. Felgines, C.; Talavera, S.; Gonthier, M. P.; Texier, O.; Scalbert, A.; Lamaison, J. L.; Remesy, C. Strawberry anthocyanins are recovered in urine as glucuro- and sulfoconjugates in humans. J. Nutr., 2003, 133(5), 1296-301.
205. Felgines, C.; Texier, O.; Besson, C.; Fraisse, D.; Lamaison, J. L.; Remesy, C. Blackberry anthocyanins are slightly bioavailable in rats. J. Nutr., 2002, 132(6), 1249-53.
206. Frank, T.; Janssen, M.; Netzet, G.; Christian, B.; Bitsch, I.; Netzel, M. Absorption and excretion of elderberry (Sambucus nigra L.) anthocyanins in healthy humans. Methods Find. Exp. Clin. Pharmacol., 2007, 29(8), 525-33.
207. Hollands, W.; Brett, G. M.; Dainty, J. R.; Teucher, B.; Kroon, P. A. Urinary excretion of strawberry anthocyanins is dose dependent for physiological oral doses of fresh fruit. Mol. Nutr. Food Res., 2008, 52(10), 1097-105.
208. Kay, C. D.; Mazza, G.; Holub, B. J.; Wang, J. Anthocyanin metabolites in human urine and serum. Br. J. Nutr., 2004, 91(6), 933-42.
209. Lietti, A.; Forni, G. Studies on Vaccinium myrtillus anthocyanosides. II. Aspects of anthocyanins pharmacokinetics in the rat. Arzneimittelforschung, 1976, 26(5), 832-5.
210. Morazzoni, P.; Livio, S.; Scilingo, A.; Malandrino, S. Vaccinium myrtillus anthocyanosides pharmacokinetics in rats. Arzneimittelforschung., 1991, 41(2), 128-31.
211. Netzel, M.; Strass, G.; Janssen, M.; Bitsch, I.; Bitsch, R. Bioactive anthocyanins detected in human urine after ingestion of blackcurrant juice. J. Environ. Pathol. Toxicol. Oncol., 2001, 20(2), 89-95.
212. Oki, T.; Suda, I.; Terahara, N.; Sato, M.; Hatakeyama, M. Determination of acylated anthocyanin in human urine after ingesting a purple-fleshed sweet potato beverage with various contents of anthocyanin by LC-ESI-MS/ MS. Biosci. Biotechnol. Biochem., 2006, 70(10), 2540-3.
213. Breen, K. J.; Schenker, S. Liver function tests. CRC Crit. Rev. Clin. Lab. Sci., 1971, 2(4), 573-99.
214. Molino, G.; Belforte, G.; Bona, B.; Frediani, S.; Cravetto, C.; Milanese, M. Qualitative and quantitative evaluation of liver diseases: functional classifications. J. Biomed. Eng., 1983, 5(3), 211-9.
215. Rosenthal, S.; White, E. Clinical application of the sulfobromophthalein test for hepatic function. J. Am. Med. Ass., 1925, 84, 1112-1114.
216. Tichy, J. A.; Loucka, M.; Trefny, Z. M. The new clearance method for hepatic diagnostics. Prague Med. Rep., 2005, 106(3), 229-42.
217. Dixon, D. P.; Lapthorn, A.; Edwards, R. Plant glutathione transferases. Genome Biol., 2002, 3(3), REVIEWS3004.
218. Moons, A. Regulatory and functional interactions of plant growth regulators and plant glutathione S-transferases (GSTs). Vitam. Horm., 2005, 72, 155-202.
219. Kreuz, K.; Tommasini, R.; Martinoia, E. Old Enzymes for a New Job (Herbicide Detoxification in Plants). Plant Physiol., 1996, 111(2), 349-353.
220. Klein, M.; Burla, B.; Martinoia, E. The multidrug resistance-associated protein (MRP/ABCC) subfamily of ATP-binding cassette transporters in plants. FEBS Lett., 2006, 580(4), 1112-22.
221. Yazaki, K. ABC transporters involved in the transport of plant secondary metabolites. FEBS Lett., 2006, 580(4), 1183-91.
222. Lu, Y. P.; Li, Z. S.; Drozdowicz, Y. M.; Hortensteiner, S.; Martinoia, E.; Rea, P. A. AtMRP2, an Arabidopsis ATP binding cassette transporter able to transport glutathione S-conjugates and chlorophyll catabolites: functional comparisons with Atmrp1. Plant Cell, 1998, 10(2), 267-82.
223. Klein, M.; Martinoia, E.; Weissenbock, G. Transport of lucifer yellow CH into plant vacuoles - evidence for direct energization of a sulphonated substance and implications for the design of new molecular probes. FEBS Lett., 1997, 420(1), 86-92.
224. Smith, N. F.; Figg, W. D.; Sparreboom, A. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opin. Drug Metab. Toxicol., 2005, 1(3), 429-45.
225. Rizwan, A. N.; Burckhardt, G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm. Res., 2007, 24(3), 450-70.
226. Kolobe, D.; Sayed, Y.; Dirr, H. W. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics. Biochem. J., 2004, 382(Pt 2), 703-9.
227. Oakley, A. J.; Lo Bello, M.; Nuccetelli, M.; Mazzetti, A. P.; Parker, M. W. The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site). J. Mol. Biol., 1999, 291(4), 913-26.
228. Litwack, G.; Ketterer, B.; Arias, I. M. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature, 1971, 234(5330), 466-7.
229. Mannervik, B.; Alin, P.; Guthenberg, C.; Jensson, H.; Tahir, M. K.; Warholm, M.; Jornvall, H. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA, 1985, 82(21), 7202-6.
230. Mannervik, B.; Danielson, U. H. Glutathione transferases - structure and catalytic activity. CRC Crit. Rev. Biochem., 1988, 23(3), 283-337.
231. Rowe, J. D.; Nieves, E.; Listowsky, I. Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem. J., 1997, 325 (Pt 2), 481-6.
232. Nies, A. T.; Keppler, D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch., 2007, 453(5), 643-59.
233. Sakka, S. G. Assessing liver function. Curr. Opin. Crit. Care, 2007, 13(2), 207-14.
234. Shibahara, S.; Kitamuro, T.; Takahashi, K. Heme degradation and human disease: diversity is the soul of life. Antioxid. Redox Signal, 2002, 4(4), 593-602.
235. Scharschmidt, B. F.; Waggoner, J. G.; Berk, P. D. Hepatic organic anion uptake in the rat. J. Clin. Invest., 1975, 56(5), 1280-92.
236. Jagt, D. L.; Wilson, S. P.; Dean, V. L.; Simons, P. C. Bilirubin binding to rat liver ligandins (glutathione S-transferases A and B). Relationship between bilirubin binding and transferase activity. J. Biol. Chem., 1982, 257(4), 1997-2001.
237. Wolkoff, A. W. The glutathione S-transferases: their role in the transport of organic anions from blood to bile. Int. Rev. Physiol., 1980, 21, 150-69.
238. Akizawa, E.; Koiwai, K.; Hayano, T.; Maezawa, S.; Matsushita, T.; Koiwai, O. Direct binding of ligandin to uridine 5′-diphosphate glucuronosyltransferase 1A1. Hepatol. Res., 2008, 38(4), 402-9.
239. Bosma, P. J.; Seppen, J.; Goldhoorn, B.; Bakker, C.; Oude Elferink, R. P.; Chowdhury, J. R.; Chowdhury, N. R.; Jansen, P. L. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem., 1994, 269(27), 17960-4.
240. Jager, W.; Winter, O.; Halper, B.; Salamon, A.; Sartori, M.; Gajdzik, L.; Hamilton, G.; Theyer, G.; Graf, J.; Thalhammer, T. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat. Hepatology, 1997, 26(6), 1467-76.
241. Jager, W.; Gehring, E.; Hagenauer, B.; Aust, S.; Senderowicz, A.; Thalhammer, T. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2). Life Sci., 2003, 73(22), 2841-54.
242. Jager, W.; Gehring, E.; Hagenauer, B.; Aust, S.; Senderowicz, A.; Thalhammer, T. The role of hepatic Mrp2 in the interaction of flavopiridol and bilirubin: impact on therapy. Int. J. Clin. Pharmacol. Ther., 2003, 41(12), 610-1.
243. van Zanden, J. J.; van der Woude, H.; Vaessen, J.; Usta, M.; Wortelboer, H. M.; Cnubben, N. H.; Rietjens, I. M. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem. Pharmacol., 2007, 74(2), 345-51.
244. Williamson, G.; Aeberli, I.; Miguet, L.; Zhang, Z.; Sanchez, M. B.; Crespy, V.; Barron, D.; Needs, P.; Kroon, P. A.; Glavinas, H.; Krajcsi, P.; Grigorov, M. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab. Dispos., 2007, 35(8), 1262-8.
245. Patanasethanont, D.; Nagai, J.; Matsuura, C.; Fukui, K.; Sutthanut, K.; Sripanidkulchai, B. O.; Yumoto, R.; Takano, M. Modulation of function of multidrug resistance associated-proteins by Kaempferia parviflora extracts and their components. Eur. J. Pharmacol., 2007, 566(1-3), 67-74.
246. Srivastava, A.; Akoh, C. C.; Fischer, J.; Krewer, G. Effect of anthocyanin fractions from selected cultivars of Georgia-grown blueberries on apoptosis and phase II enzymes. J. Agric. Food Chem., 2007, 55(8), 3180-5.
247. Rigato, I.; Cravatari, M.; Avellini, C.; Ponte, E.; Croce, S. L.; Tiribelli, C. Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1. Nat. Clin. Pract. Gastroenterol. Hepatol., 2007, 4(7), 403-8.
248. Joseph, T. B.; Wang, S. W.; Liu, X.; Kulkarni, K. H.; Wang, J.; Xu, H.; Hu, M. Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol. Pharm., 2007, 4(6), 883-94.
249. Lee, H. S.; Ji, H. Y.; Park, E. J.; Kim, S. Y. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes. Xenobiotica, 2007, 37(8), 803-17.
250. Sridar, C.; Goosen, T. C.; Kent, U. M.; Williams, J. A.; Hollenberg, P. F. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. Drug Metab. Dispos., 2004, 32(6), 587-94.
251. Flaig, T. W.; Gustafson, D. L.; Su, L. J.; Zirrolli, J. A.; Crighton, F.; Harrison, G. S.; Pierson, A. S.; Agarwal, R.; Glode, L. M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest. New Drugs, 2007, 25(2), 139-46.
252. Watchko, J. F. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin. Perinatol., 2006, 33(4), 839-52; abstract ix.
253. McDonagh, A. F.; Lightner, D. A.; Kar, A. K.; Norona, W. S. Hepatobiliary excretion of biliverdin isomers and C10-substituted biliverdins in Mrp2-deficient (TR(-)) rats. Biochem. Biophys. Res. Commun., 2002, 293(3), 1077-83.
254. Barrowman, J. A.; Bonnett, R.; Bray, P. J. Metabolism of biliverdin. Biliary excretion of bile pigments after intravenous injection of biliverdin isomers. Biochim. Biophys. Acta, 1976, 444(2), 333-7.
255. Stocker, R.; Glazer, A. N.; Ames, B. N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA, 1987, 84(16), 5918-22.
256. McDonagh, A. F. Is bilirubin good for you? Clin. Perinatol., 1990, 17(2), 359-69.
257. Berk PD, H. R., Bloomer JR and Berlin NI. Studies on bilirubin kinetics in normal adults. J. Clin. Invest., 1969, 48, 2176-2190.
258. Galbraith, R. Heme oxygenase: who needs it? Proc. Soc. Exp. Biol. Med., 1999, 222(3), 299-305.
259. Kirkby, K. A.; Adin, C. A. Products of heme oxygenase and their potential therapeutic applications. Am. J. Physiol. Renal. Physiol., 2006, 290(3), F563-71.
260. Vitek, L.; Schwertner, H. A. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv. Clin. Chem., 2007, 43, 1-57.
261. Baranano, D. E.; Rao, M.; Ferris, C. D.; Snyder, S. H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA, 2002, 99(25), 16093-8.
262. Pietta, P. G. Flavonoids as antioxidants. J. Nat. Prod., 2000, 63(7), 1035-42.
263. Schwertner, H. A.; Vitek, L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis, 2008, 198(1), 1-11.
264. Gould, K. S.; Lister, C. Flavonoid Functions in Plants. In Flavonoids: chemistry, Biochemistry, and Applications; Andersen, Ø. M.; Markham, K. R., Eds.; CRC Press, Taylor & Francis Group: Boca Raton, FL, 2006, pp. 397-442.
265. Kitamura, S. Transport of Flavonoids. From Cytosolic Synthesis to Vacuolar Accumulation In The Science of Flavonoids; Grotewold, E., Ed. Springer New York, 2006; pp 123-146.
266. Shirley, B. W. Flavonoid biosynthesis: 'new' functions for an 'old' pathway Trends Plant Sci., 1996, 1(11), 377-382
267. Springob, K.; Nakajima, J.; Yamazaki, M.; Saito, K. Recent advances in the biosynthesis and accumulation of anthocyanins. Nat. Prod. Rep., 2003, 20(3), 288-303.
268. Winkel, B. S. J. I. G. E. E., Science of Flavonoids. Berlin, Springer 2006; 71-95. The Biosynthesis of Flavonoids. In The Science of Flavonoids; Grotewold, E., Ed.; Speringer: New York, 2006, pp. 71-95.
269. Winkel-Shirley, B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol., 2001, 126(2), 485-93.
270. Stafford, H. A. Possible multienzyme complexes regulating the formation of C6-C3 phenolic compounds and lignins in higher plants. Rec. Adv. Phytochem., 1974, 8, 53-79.
271. Winkel, B. S. J. Evidence of enzyme complexes in the phenylpropanoid and flavonoid pathways. Physiol. Plant., 1999, 107, 142-149.
272. Saslowsky, D.; Winkel-Shirley, B. Localization of flavonoid enzymes in Arabidopsis roots. Plant J., 2001, 27(1), 37-48.
273. Tian, L.; Wan, S.-B.; Pan, Q.-H.; Zheng, Y.-J.; Huang, W.-D. A novel plastid localization of chalcone synthase in developing grape berry. Plant Sci., 2008, 175, 431-436.
274. Grotewold, E. The genetics and biochemistry of floral pigments. Annu. Rev. Plant Biol., 2006, 57, 761-80.
275. Kutchan, T. M. A role for intra- and intercellular translocation in natural product biosynthesis. Curr. Opin. Plant Biol., 2005, 8(3), 292-300.
276. Grotewold, E. Subcellular trafficking of phytochemicals. Rec. Res. Dev. Plant Physiol., 2001, 2, 31-48.
277. Grotewold, E. The challenges of moving chemicals within and out of cells: insights into the transport of plant natural products. Planta, 2004, 219(5), 906-9.
278. Poustka, F.; Irani, N. G.; Feller, A.; Lu, Y.; Pourcel, L.; Frame, K.; Grotewold, E. A trafficking pathway for anthocyanins overlaps with the endoplasmic reticulum-to-vacuole protein-sorting route in Arabidopsis and contributes to the formation of vacuolar inclusions. Plant Physiol., 2007, 145(4), 1323-35.
279. Parham, R. A.; Kaustinen, H. M. On the site of tannin synthesis in plant cells. Bot. Gaz., 1977, 138, 456-457.
280. Winkel-Shirley, B. Biosynthesis of flavonoids and effects of stress. Curr. Opin. Plant Biol., 2002, 5(3), 218-23.
281. Castellarin, S. D.; Pfeiffer, A.; Sivilotti, P.; Degan, M.; Peterlunger, E.; G, D. I. G. Transcriptional regulation of anthocyanin biosynthesis in ripening fruits of grapevine under seasonal water deficit. Plant Cell Environ., 2007, 30(11), 1381-99.
282. Yazaki, K. Transporters of secondary metabolites. Curr. Opin. Plant Biol., 2005, 8(3), 301-7.
283. Rea, P. A. Plant ATP-binding cassette transporters. Annu. Rev. Plant Biol., 2007, 58, 347-75.
284. Martinoia, E.; Maeshima, M.; Neuhaus, H. E. Vacuolar transporters and their essential role in plant metabolism. J. Exp. Bot., 2007, 58(1), 83-102.
285. Goodman, C. D.; Casati, P.; Walbot, V. A multidrug resistance-associated protein involved in anthocyanin transport in Zea mays. Plant Cell, 2004, 16(7), 1812-26.
286. Frangne, N.; Eggmann, T.; Koblischke, C.; Weissenbock, G.; Martinoia, E.; Klein, M. Flavone glucoside uptake into barley mesophyll and Arabidopsis cell culture vacuoles. Energization occurs by H(+)-antiport and ATP-binding cassette-type mechanisms. Plant Physiol., 2002, 128(2), 726-33.
287. Klein, M.; Weissenbock, G.; Dufaud, A.; Gaillard, C.; Kreuz, K.; Martinoia, E. Different energization mechanisms drive the vacuolar uptake of a flavonoid glucoside and a herbicide glucoside. J. Biol. Chem., 1996, 271(47), 29666-71.
288. Marinova, K.; Pourcel, L.; Weder, B.; Schwarz, M.; Barron, D.; Routaboul, J. M.; Debeaujon, I.; Klein, M. The Arabidopsis MATE transporter TT12 acts as a vacuolar flavonoid/H+ -antiporter active in proanthocyanidin-accumulating cells of the seed coat. Plant Cell, 2007, 19(6), 2023-38.
289. Debeaujon, I.; Peeters, A. J.; Leon-Kloosterziel, K. M.; Koornneef, M. The TRANSPARENT TESTA12 gene of Arabidopsis encodes a multidrug secondary transporter-like protein required for flavonoid sequestration in vacuoles of the seed coat endothelium. Plant Cell, 2001, 13(4), 853-71.
290. Marinova, K.; Kleinschmidt, K.; Weissenbock, G.; Klein, M. Flavonoid biosynthesis in barley primary leaves requires the presence of the vacuole and controls the activity of vacuolar flavonoid transport. Plant Physiol., 2007, 144(1), 432-44.
291. Braidot, E.; Petrussa, E.; Bertolini, A.; Peresson, C.; Ermacora, P.; Loi, N.; Terdoslavich, M.; Passamonti, S.; Macri, F.; Vianello, A. Evidence for a putative flavonoid translocator similar to mammalian bilitranslocase in grape berries (Vitis vinifera L.) during ripening. Planta, 2008, 228(1), 203-13.
292. Zhang, H.; Wang, L.; Deroles, S.; Bennett, R.; Davies, K. New insight into the structures and formation of anthocyanic vacuolar inclusions in flower petals. BMC Plant Biol., 2006, 6, 29-43.
293. Terrier, N.; Sauvage, F. X.; Ageorges, A.; Romieu, C. Changes in acidity and in proton transport at the tonoplast of grape berries during development. Planta, 2001, 213(1), 20-8.
294. Grimplet, J.; Deluc, L. G.; Tillett, R. L.; Wheatley, M. D.; Schlauch, K. A.; Cramer, G. R.; Cushman, J. C. Tissue-specific mRNA expression profiling in grape berry tissues. BMC Genomics, 2007, 8, 187-210.
295. Castellarin, S. D.; Matthews, M. A.; Di Gaspero, G.; Gambetta, G. A. Water deficits accelerate ripening and induce changes in gene expression regulating flavonoid biosynthesis in grape berries. Planta, 2007, 227(1), 101-12.
296. Coombe, B. G.; McCarthy, M. Dynamics of grape berry growth and physiology of ripening. Aust. J. Grape Wine Res., 2000, 6, 131-5.
297. Bondada, B. R.; Matthews, M. A.; Shackel, K. A. Functional xylem in the post-veraison grape berry. J. Exp. Bot., 2005, 56(421), 2949-57.
298. Zhang, X. Y.; Wang, X. L.; Wang, X. F.; Xia, G. H.; Pan, Q. H.; Fan, R. C.; Wu, F. Q.; Yu, X. C.; Zhang, D. P. A shift of Phloem unloading from symplasmic to apoplasmic pathway is involved in developmental onset of ripening in grape berry. Plant Physiol., 2006, 142(1), 220-32.